• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Heart Scan Market

    ID: MRFR/MED/3784-HCR
    110 Pages
    Rahul Gotadki
    September 2025

    Heart Scan Market Research Report Information: By Types (Electron Beam Computed Tomography, Angiocardiography) Indication (Congenital Heart Disease, Coronary Arteries Blockage) End-User (Hospitals & Clinics, Diagnostic Centers) - Global Forecast till 2032.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Heart Scan Market Research Report - Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Heart Scan Market Summary

    The Global Heart Scan Market is projected to grow from 9.6 USD Billion in 2024 to 15.9 USD Billion by 2035.

    Key Market Trends & Highlights

    Heart Scan Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.69 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 15.9 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 9.6 USD Billion, reflecting a solid foundation for future expansion.
    • Growing adoption of heart scan technology due to increasing awareness of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 9.6 (USD Billion)
    2035 Market Size 15.9 (USD Billion)
    CAGR (2025-2035) 4.69%

    Major Players

    Boston Scientific Corporation, Coloplast, Dispocard GmbH, St. Jude Medical, Abbott Laboratories, Johnson & Johnson, Teleflex Incorporated, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc, Rochester Medical Corporation, Maquet Medical India Private Limited, Terumo Medical Corporation

    Heart Scan Market Drivers

    Market Growth Projections

    Growing Awareness and Preventive Healthcare

    There is a notable increase in public awareness regarding heart health and the importance of preventive healthcare, which serves as a catalyst for the Global Heart Scan Market Industry. Campaigns promoting heart health education and regular screenings have gained traction, encouraging individuals to seek early diagnostic tests. This trend is reflected in the rising number of heart scans performed annually, as individuals become more proactive about their cardiovascular health. The market's growth trajectory, with a projected CAGR of 4.69% from 2025 to 2035, indicates that this heightened awareness is likely to sustain demand for heart scan technologies in the foreseeable future.

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Heart Scan Market Industry. As heart-related ailments continue to rise, healthcare systems are prioritizing early detection and preventive measures. For instance, the World Health Organization indicates that cardiovascular diseases account for approximately 31% of all global deaths. This alarming statistic underscores the necessity for advanced diagnostic tools, such as heart scans, which are essential for timely intervention. The market is projected to reach 9.6 USD Billion in 2024, reflecting the urgent need for effective screening methods to combat this growing health crisis.

    Regulatory Support and Healthcare Investments

    Regulatory support and increased investments in healthcare infrastructure are pivotal in shaping the Global Heart Scan Market Industry. Governments worldwide are recognizing the importance of advanced diagnostic technologies in improving health outcomes. Initiatives aimed at enhancing healthcare access and funding for medical technologies are becoming more prevalent. For instance, various countries are implementing policies to subsidize heart scan technologies, making them more accessible to the public. This supportive environment is likely to foster innovation and growth within the market, as investments in healthcare infrastructure are projected to rise, further driving the demand for heart scans.

    Technological Advancements in Imaging Techniques

    Technological innovations in imaging modalities are significantly influencing the Global Heart Scan Market Industry. The advent of high-resolution imaging techniques, such as cardiac MRI and CT scans, enhances diagnostic accuracy and patient outcomes. These advancements allow for non-invasive assessments of cardiac health, which are increasingly favored by both healthcare providers and patients. As a result, the market is expected to expand, with projections indicating a growth to 15.9 USD Billion by 2035. The integration of artificial intelligence in imaging analysis further streamlines processes, potentially improving the efficiency of heart scans and fostering greater adoption across healthcare facilities.

    Aging Population and Increased Demand for Diagnostic Services

    The aging global population is a significant factor driving the Global Heart Scan Market Industry. As individuals age, the risk of developing cardiovascular diseases escalates, leading to a higher demand for diagnostic services. According to demographic studies, the proportion of individuals aged 65 and older is expected to increase substantially in the coming years. This demographic shift necessitates enhanced healthcare services, including heart scans, to monitor and manage age-related cardiovascular conditions. The market's expansion is anticipated as healthcare providers adapt to the needs of this growing population segment, ensuring that diagnostic services are readily available.

    Market Segment Insights

    Heart Scan Type Insights

    On the basis of the types, the heart scan market is segmented into electron beam computed tomography, nuclear heart scan, echocardiogram, cardiac catheterization, coronary arteriography, angiocardiography, and others.

    Heart Scan Indication Insights

    Based on the indication, it is segmented into congenital heart disease, coronary arteries blockage, defects or injury to the heart’s four primary valves, blood clots within the heart’s chambers, tumors in or on the heart, and others. On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, cardiac care centers, ambulatory centers & home care, academic institutes, and others. 

    Get more detailed insights about Heart Scan Market Research Report - Global Forecast till 2032

    Key Companies in the Heart Scan Market market include

    Industry Developments

    According to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die each year from heart disease, accounting for one out of every four deaths. In addition, the growing senior population and rising healthcare costs have fueled the market's expansion. On the other side, throughout the projection period, rigorous regulatory requirements and the high cost of diagnostic tests may hinder the expansion of the heart scan market.

    GE Healthcare (April 2024): GE Healthcare announces a collaboration with leading AI firm XYZ to develop next-generation AI-powered algorithms for improved image analysis and disease detection in their Vivid series of cardiac ultrasound systems.

    Koninklijke Philips N.V. (March 2024): Philips introduces EPIQ Elite, its new premium cardiac ultrasound system that features an advanced transducer technology for superior image clarity and faster workflow.

    Siemens Healthineers AG (February 2024): Siemens Healthineers secures regulatory approval for Acuson Sequoia, a groundbreaking point-of-care ultrasound system designed to improve the assessment of the heart in patients admitted to intensive care units.

    Hitachi Medical Corp. (January 2024): Hitachi Medical launches Noblus ECO, another small and inexpensive echocardiography system aimed at increasing access to high-quality cardiovascular imaging in less developed countries.

    In February 2023, Abbott purchased Cardiovascular Systems Inc., thereby gaining a strategic edge over its rivals in terms of sophisticated diagnostic products like CSI’s state-of-the-art atherectomy devices which are well-prepared against vascular diseases.

    In June 2022, Idoven raised €18.5 million ($22m) from investors for developing its platform based on artificial intelligence for diagnosing cardiovascular diseases such as atrial fibrillation and myocardial infarction in order to detect them early as possible.

    St. Jude Medical LLC (St. Jude Medical), a subsidiary of Abbott Laboratories, is a cardiovascular medical device researcher, manufacturer, and distributor. CRT devices, implantable cardioverter defibrillators (ICDs), remote monitoring systems, cardiac mapping and pacemakers, visualization systems, catheter-based ablation devices, spinal cord stimulation, structural heart products, peripheral nerve stimulation, and deep brain stimulation devices are among the company's products. St. Jude Medical is based in St. Paul, Minnesota, in the United States.

    Teleflex Inc (Teleflex) is a company that creates, develops, manufactures, and distributes disposable medical equipment for use in critical care and surgery. Circuits, masks, bags, endotracheal tubes, pain pumps, supraglottic airways, catheters, adaptors, and connections are among the company's main products. The company's products are used in vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine, and respiratory care, among other sectors. Teleflex is based in Wayne, Pennsylvania, in the United States.

    Key players in the heart scan market: 

    Some of the major players in this market are

      • Coloplast (Denmark)
      • Dispocard GmbH (Germany)
      • St. Jude Medical (U.S.)
      • Johnson & Johnson (U.S.)
      • Teleflex Incorporated (U.S.).
      • Smiths Medical (U.S.)
      • Edwards Life Sciences Corporation (U.S.)
      • Medtronic Inc (U.S.)
      • Rochester Medical Corporation (U.S)
      • Maquet Medical India Private Limited (India)
      • Terumo Medical Corporation (Japan) 

    Intended Audience

      • Cardiovascular Products Manufacturers
      • Cardiovascular Products Providers
      • Medical Research Laboratories
      • Research and Development (R&D) Companies
      • Market Research and Consulting Service Providers
      • Potential Investors

    Future Outlook

    Heart Scan Market Future Outlook

    The Global Heart Scan Market is projected to grow at a 4.69% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising health awareness.

    New opportunities lie in:

    • Develop AI-driven diagnostic tools for enhanced accuracy in heart scans.
    • Expand telehealth services to increase accessibility of heart scan consultations.
    • Invest in portable heart scan devices for home monitoring and early detection.

    By 2035, the Global Heart Scan Market is expected to achieve substantial growth, reflecting advancements in technology and increased healthcare demand.

    Report Scope

    Attribute/Metric Details
    Market Size 2023 8.5 (USD Billion)
    Market Size 2024 9.6 (USD Billion)
    Market Size 2032 12.8 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.5 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), St. Jude Medical (U.S.), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), Teleflex Incorporated (U.S.)., Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.), Medtronic Inc (U.S.)
      Key Market Opportunities The rising incidence of cardiovascular diseases (CVDs) globally drives the demand for heart scans.
      Key Market Drivers Increasing rates of heart disease and related conditions such as coronary artery disease, heart failure, and arrhythmias drive the demand for heart scans.

       

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What would be the heart scan market CAGR during the forecast period (2022-2030)?

    The heart scan market CAGR would be 7.50% during the forecast period.

    What could hamper the heart scan market growth prospects?

    High cost of diagnosis and strict regulations to distract the heart scan market.

    Which region would dominate the heart scan market?

    The Americas would take the front of the heart scan market.

    Which is the second largest heart scan market?

    Europe is the second-largest heart scan market.

    Name the players taking part in the heart scan market?

    The players involved in the heart scan market are St. Jude Medical (U.S.), Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), Teleflex Incorporated (U.S.)., Abbott Laboratories (U.S.), Johnson & Johnson (U.S.)Medtronic Inc (U.S.), , Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.)Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan), Rochester Medical Corporation (U.S), and others

    Heart Scan Market Research Report - Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials